MARMIROLI, PAOLA LORENA
 Distribuzione geografica
Continente #
NA - Nord America 13.479
EU - Europa 6.503
AS - Asia 3.077
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 14
AF - Africa 11
Totale 23.119
Nazione #
US - Stati Uniti d'America 13.207
DE - Germania 1.202
CN - Cina 1.155
SE - Svezia 1.093
IT - Italia 1.038
SG - Singapore 977
IE - Irlanda 862
UA - Ucraina 654
RU - Federazione Russa 614
VN - Vietnam 378
GB - Regno Unito 363
HK - Hong Kong 280
CA - Canada 263
AT - Austria 170
FI - Finlandia 156
FR - Francia 116
DK - Danimarca 100
IN - India 87
TR - Turchia 47
JP - Giappone 45
NL - Olanda 43
ID - Indonesia 34
KR - Corea 25
BE - Belgio 22
EU - Europa 16
AU - Australia 14
PL - Polonia 13
IR - Iran 11
BR - Brasile 10
MY - Malesia 10
CZ - Repubblica Ceca 9
ES - Italia 9
RO - Romania 9
TW - Taiwan 9
BG - Bulgaria 7
MX - Messico 6
GR - Grecia 5
CH - Svizzera 4
EG - Egitto 4
NZ - Nuova Zelanda 4
RS - Serbia 4
IL - Israele 3
NO - Norvegia 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CL - Cile 2
GT - Guatemala 2
HR - Croazia 2
NG - Nigeria 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
EE - Estonia 1
IQ - Iraq 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
PA - Panama 1
PT - Portogallo 1
SA - Arabia Saudita 1
TZ - Tanzania 1
ZA - Sudafrica 1
Totale 23.119
Città #
Ann Arbor 2.915
Woodbridge 1.169
Houston 1.017
Chandler 864
Dublin 840
Fairfield 808
Singapore 774
Frankfurt am Main 760
Wilmington 705
Jacksonville 694
Ashburn 583
Dearborn 518
Milan 401
New York 349
Princeton 328
Santa Clara 318
Seattle 306
Hong Kong 280
Cambridge 271
Nanjing 214
Dong Ket 207
Boardman 190
Vienna 168
Altamura 131
Shanghai 125
Beijing 117
Lachine 111
Lawrence 109
Guangzhou 88
Nanchang 73
Toronto 68
Grafing 67
Shenyang 60
San Diego 57
Ottawa 48
Andover 47
Chicago 46
Fremont 46
Hebei 44
Jiaxing 43
Jinan 41
Hangzhou 38
Helsinki 38
Los Angeles 37
Falls Church 36
Jakarta 33
Changsha 31
Sacramento 31
Tianjin 31
Carate Brianza 30
Detroit 29
Pune 29
Rome 29
Norwalk 28
Kunming 27
Dallas 26
Edmonton 22
Huizen 22
Shangdi 22
Zhengzhou 22
Mountain View 21
Nürnberg 21
Hefei 20
Brussels 17
Tokyo 17
London 16
Ningbo 15
Taizhou 15
Melzo 14
Auburn Hills 12
Codroipo 12
Kiev 11
Munich 11
San Mateo 11
Fuzhou 10
Kraków 9
Leawood 9
Mainz 9
Paris 9
Bergamo 8
Tappahannock 8
Cagliari 7
Canazei 7
Chengdu 7
Lissone 7
Piemonte 7
Redmond 7
Regensburg 7
Sesto San Giovanni 7
Somma Lombardo 7
Washington 7
Changchun 6
Daejeon 6
Florence 6
Monmouth Junction 6
Perugia 6
Philadelphia 6
Phoenix 6
University Park 6
Varese 6
Totale 16.960
Nome #
In vivo comparative study on acute and sub-acute biological e_ects induced by ultrafine particles of different anthropogenic sources in balb/c mice 381
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 297
Age-related changes in the function and structure of the peripheral sensory pathway in mice 296
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 292
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 284
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 280
Systemic exposure to air pollution induces oxidative stress and inflammation in mouse brain, contributing to neurodegeneration onset 280
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 263
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 239
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 235
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 233
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 232
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 217
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 214
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 208
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 208
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 207
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 200
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 199
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 197
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 195
Histological features of nerve fibers and endoneural vessels in a case of Wegener's granulomatosis. 186
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 185
Pain in chemotherapy-induced peripheral neurotoxicity 185
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 185
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 184
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 183
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 183
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 181
Treatment of patients with neuropathy and anti-MAG IgM M-proteins. 179
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 178
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 177
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 177
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 173
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 172
A clinico-pathological and follow up study of 10 cases of essential type II cryoglobulinaemic neuropathy 171
OCT2 transporter involvement in development of cisplatin toxicity 171
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 171
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 170
Ultrastructural organization of lamina VI of the spinal cord of the cat. 169
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 167
Expression, distribution and glutamate uptake activity of high affinity-excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 167
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 165
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 163
Lipid-free versus lipid-bound P2 protein-induced experimental allergic neuritis: Clinicopathological, neurophysiological, and immunological study 163
Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia. 162
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 161
Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats 161
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 161
Effects induced by particles derived from two anthropogenic sources on respiratory, cardiovascular and central nervous systems 159
Anti-sulfatide IgM antibodies in peripheral neuropathy 158
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 158
Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies 158
Cryoglobulinaemic neuropathy: lack of progression in patients with good haematological control 158
Current view in platinum drug mechanisms of peripheral neurotoxicity 157
Peripheral nervous system involvement in Niemann-Pick disease type 156
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 154
Neurotoxicity of oxaliplatin (I-OHP) in rats and influence of scheduling 154
Neurotrophin effect on the SH-SY5Y human neuroblastoma (HN) model of CDDP-induced neurotoxicity 154
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 153
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation 152
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 151
Focus on the role of Glutamate in the pathology of the peripheral nervous system 151
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 151
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 151
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 151
Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat 149
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 147
Chemotherapy-induced peripheral neurotoxicity 145
Drugs for the treatment of peripheral neuropathies 145
Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy 142
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity 141
Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity? 141
Peripheral neuropathy in macroglobulinemia: incidence and antigen-specificity of M proteins. 140
Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved 139
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 139
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 137
Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity 137
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 137
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 135
Sialidosis type I: pathological study in an adult. 134
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 133
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 133
Proteasome inhibition: a promising strategy for treating cancer, but what about neurotoxicity? 132
Effects of repeated administration of low doses of cisplatin on the rat nervous system. 132
The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity 132
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 131
Neurotrophins: effect on cisplatin-induced cytotoxicity and neurotoxicity in SH-SY5Y cells 130
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 130
Multimodal experimental approach to the study of human neurological diseases 129
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 128
Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity 127
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 127
Management of oxaliplatin-induced peripheral sensory neuropathy 127
The role of growth factors in the prevention and treatment of chemotherapy-induced peripheral neurotoxicity 126
Imunohystochemical characterization of the distribution of glutamate receptors, “high affinity” membrane bound glutamate transporters and of Glutamate Carboxipeptidase II (GCPII) in in vitro cultures of embryonic dorsal root ganglia. 126
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 126
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 126
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 125
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 125
Totale 17.186
Categoria #
all - tutte 78.427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.427


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.779 0 0 0 0 387 511 605 274 371 297 258 76
2020/20213.819 167 146 460 379 295 311 377 331 312 302 200 539
2021/20222.152 161 223 234 242 155 240 108 95 91 123 138 342
2022/20233.624 398 1.018 372 368 278 575 53 157 255 36 56 58
2023/20242.673 98 88 110 93 334 650 521 140 158 42 37 402
2024/20252.478 390 809 519 301 459 0 0 0 0 0 0 0
Totale 24.391